2021
DOI: 10.1530/raf-21-0015
|View full text |Cite
|
Sign up to set email alerts
|

Study design flaws and statistical challenges in evaluating fertility treatments

Abstract: Health interventions should be tested before being introduced into clinical practice, to find out whether they work and whether they are harmful. However, research studies will only provide reliable answers to these questions if they are appropriately designed and analysed. But these are not trivial tasks. We review some methodological challenges that arise when evaluating fertility interventions and explain the implications for a non-statistical audience. These include flexibility in outcomes and analyses; us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 87 publications
0
4
0
Order By: Relevance
“…Other limitations, contributing to significant heterogeneity, include variability in clinical populations and diets, both geographically and culturally, as well as in their methodology. These concerns and their implications have already been highlighted in other research in the area [49]. We also note limitations inherent to FFQs such as risk of recall and social approval bias [50].…”
Section: Strengths and Limitationsmentioning
confidence: 67%
“…Other limitations, contributing to significant heterogeneity, include variability in clinical populations and diets, both geographically and culturally, as well as in their methodology. These concerns and their implications have already been highlighted in other research in the area [49]. We also note limitations inherent to FFQs such as risk of recall and social approval bias [50].…”
Section: Strengths and Limitationsmentioning
confidence: 67%
“…That is, women who are able to conceive naturally sooner after a preceding CPL (ie, shorter IPI) may have better fecundity, whereas women with a longer IPI are more likely to experience compromised fecundity or subfertility, resulting in a lower likelihood of achieving live birth that possibly counteracts the benefit of longer IPIs on pregnancy outcomes. 18 Although the results remained unaltered when taking into account the duration of trying to conceive, 14,19 there may have been a possibility of self-reporting bias or recall bias (eg, the estimated date of the last menstrual period or the recall of the duration couples spent trying to conceive). In addition, we observed a higher risk of biochemical pregnancy loss among women with an IPI of less than 3 months compared with those with an IPI of 6 to 12 months.…”
Section: Discussionmentioning
confidence: 98%
“…In most of the previous studies in naturally conceiving populations, IPI length was generally defined as the period between the end of the preceding CPL and the onset of the last menstrual cycle of the next pregnancy, which was likely confounded by female fecundity. That is, women who are able to conceive naturally sooner after a preceding CPL (ie, shorter IPI) may have better fecundity, whereas women with a longer IPI are more likely to experience compromised fecundity or subfertility, resulting in a lower likelihood of achieving live birth that possibly counteracts the benefit of longer IPIs on pregnancy outcomes . Although the results remained unaltered when taking into account the duration of trying to conceive, there may have been a possibility of self-reporting bias or recall bias (eg, the estimated date of the last menstrual period or the recall of the duration couples spent trying to conceive).…”
Section: Discussionmentioning
confidence: 98%
“…Their value, however, depends on the study design, and the pitfalls of fertility-related study designs have been well outlined in the literature. 154 Moreover, reviewers may find evaluating study designs difficult and a critical appraisal framework for this type of research may be needed. 155 One also needs to address questions of authorship and conflicts of interest such as whether simply providing access to a dataset would be sufficient to be listed as an author, and the possibility of conflicts of interest, 156 such as when an executive of an IVF clinic hands over access to medical records in exchange for pecuniary gain such as start-up shares.…”
Section: Publication and Research Standardsmentioning
confidence: 99%